Aurobindo Pharma has provided an update regarding its plan to enter a captive solar power purchase agreement and acquire up to a 26% stake in Swarnaakshu Solar Power Private Limited. Due to pending state government approval for the solar plant, the required investment for the 26% stake acquisition will now be completed on or before June 30, 2026. This extension follows previous communications related to the target completion date of March 31, 2026.
Extension for Captive Solar Investment
Aurobindo Pharma Limited issued this communication on March 30, 2026, addressing the progress of its renewable energy initiatives. The company refers to previous letters outlining its intention to secure a captive solar power purchase agreement and acquire a stake of up to 26% in Swarnaakshu Solar Power Private Limited (“Swarnaakshu”).
Revised Timeline for Acquisition
The original deadline communicated for finalizing this arrangement was March 31, 2026. However, due to pending receipt of state government approval required for setting up the captive solar power plant, the timeline for completing the investment has been formally extended. The company now confirms that the required investment for acquiring the 26% stake in Swarnaakshu will be completed on or before June 30, 2026. This completion remains subject to the receipt of approval from the concerned state government.
Reference Documentation
This update follows prior disclosures made by the company on February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, and December 30, 2025.
Source: BSE
